Marius Ilié

1981 -

учебное заведение: Университет Ниццы — Софии Антиполис

род занятий: исследователь

Серия

There is nothing here

Создать новую серию

Произведения

There is nothing here

Создать новое произведение

Статьи 94

Дата

Заголовок

Авторы

2023-02-09

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens

Marius Ilié, Jonathan Benzaquen, Elodie Long, Jacques Boutros, Christophe Bontoux, Charles Marquette, Paul Hofman
2022-06-06

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

Dingxie Liu, Jonathan Benzaquen, Luc G T Morris, Marius Ilié, Paul Hofman
2020-04-13

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

Simon Heeke, Jonathan Benzaquen, Jacques Boutros, Charles Marquette, Marius Ilié
2019-08-15

The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress

Marius Ilié, Nicolas Nottet, Pascal Barbry, Georges Vassaux, Paul Hofman, Bernard Mari, Virginie Magnone
2019-07-01

Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

Pierre Saintigny, Paul Hofman, Marius Ilié
2019-08-05

"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy

Pierre O Fiset, Marius Ilié, Enrico Munari, David L Rimm, Rasmus Røge, Andreas H Scheel, Ming-Sound Tsao, Ka Fai To, Fred R Hirsch
2019-02-21

The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again

Paul Hofman, Pascal Barbry, Frédéric Checler, Gael Cristofari, Marius Ilié, Bernard Mari, Charles Marquette, Pierre Saintigny, Ellen Van Obberghen-Schilling
2019-02-27

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?

Eric Tartour, Marius Ilié
2019-02-23

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

Simon Heeke, Charles Marquette, Marius Ilié
2019-10-18

Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma

Jean-Philippe Lacour, Thierry Passeron, Marius Ilié
2018-02-07

Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients

Paul Hofman, Marius Ilié
2018-05-01

Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions

Marius Ilié, Simon Heeke
2018-02-07

[The biological rationale for immunotherapy in cancer].

Jonathan Benzaquen, Paul Hofman, Marius Ilié
2018-01-01

Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer.

Marius Ilié, Paul Hofman
2018-03-21

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients

Simon Heeke, Jonathan Benzaquen, Marius Ilié
2018-04-13

Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma

Marius Ilié
2018-04-01

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition

Marius Ilié, Baharia Mograbi, Patrick Brest
2018-04-05

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site

Philippe Rochaix, Marius Ilié
2018-03-13

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Simon Heeke, Marius Ilié, Paul Hofman
2018-06-11

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA

Mehdi Kara-Borni, Simon Heeke, Marius Ilié
2018-10-15

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

Andréanne Gagné, Pierre Saintigny, Paul Hofman, Marius Ilié
2018-09-25

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Marius Ilié
2018-07

Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients

Baharia Mograbi, Marius Ilié, Paul Hofman
2018-09-18

Dermoscopy of eccrine angiomatous hamartoma: The spitzoid pattern

Marius Ilié, Christine Chiaverini
2018-09-17

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?

Paul Hofman, Marius Ilié
2018-09-13

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma

Renaud Schiappa, Marius Ilié
2018-12-01

Spotlight on tumor mutational burden in patients with non-small cell lung carcinoma

Marius Ilié
2018-11-16

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients

Marius Ilié
2018-06-19

[Carcinoma of unknown primary. Role of the pathologist in 2018: Introduction]

Philippe Rochaix, Marius Ilié
2018-06-19

[Carcinoma of unknown primary. Case no. 7]

Marius Ilié
2018-06-29

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Simon Heeke, Mehdi Kara-Borni, Marius Ilié
2018-07-19

Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells

Thomas Bertero, Sabrina Pisano, Caroline Bailleux, Alexander Emelyanov, Marius Ilié, Paul Hofman, Guerrino Meneguzzi, Dmitry V Bulavin, Cédric Gaggioli

Human - wd:Q61093628

Добро пожаловать в Inventaire

the library of your friends and communities

узнать больше